News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

ViveBio's ViveST™ Specimen Storage and Transportation Device Featured in Presentation at 5th Annual Next Generation Dx Summit


8/12/2013 10:12:39 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

ALPHARETTA, Ga., Aug. 12, 2013 /PRNewswire/ -- ViveBio, LLC announced today that its specimen storage and transportation device, ViveST, will be featured in a presentation at the 5th Annual Next Generation Dx Summit being held August 20-22, 2013, in Washington, DC. The presentation entitled, A Novel, 2nd Generation Device for Ambient Storage and Transportation for Downstream Infectious Disease Testing: ViveST will be presented Thursday, August 22,2013 at 4:05 pm.

Infectious disease monitoring often requires collection sites to ship patient samples to reference laboratories, requiring careful temperature control and special packaging. In this presentation, data evaluating the stability and quantitative reproducibility of infectious plasma specimens stored on ViveST and analyzed with quantitative RT-PCR and genotyping sequencing technologies will be presented. The data shows how ViveST can offer an accurate and reproducible global solution that enhances access to healthcare and significantly reduces the burden associated with shipping frozen samples for quantitative and sequencing-based molecular diagnostic tests.

The key feature of the ViveST is a proprietary absorbent matrix onto which a biological specimen can be loaded by simple pipetting and allowed to dry. During the drying process, water in the biological sample is evaporated but biological analytes including proteins, virions and nucleic acids remain in the matrix. The dried sample can be easily reconstituted into a robust specimen that can be used in multiple downstream applications including RNA/DNA targets, cell recovery, and protein analysis, allowing for use with such tests as viral load quantification, viral genotyping and sequencing.

ViveST is CE marked and has received ANVISA medical device registration in Brazil. For more information regarding ViveST and recent scientific publications and posters, please visit the ViveBio website at www.vivebio.com or contact Richard Carroll, PhD, at carroll@vivebio.com or Brad Nelson at nelson@vivebio.com or 877-814-7004.

About ViveBio, LLC

ViveBio, LLC is a privately held biotechnology company focused on providing cost-effective solutions for biological specimen transportation and storage. ViveBio's mission is to expand access to healthcare and extend life through these cost effective solutions and other breakthrough technologies. The company's initial focus has been to address the need for transporting plasma for quantitative HIV, Hepatitis C and Hepatitis B viral load and genotype tests. ViveBio's manufacturing and corporate office is located in Alpharetta, Georgia.

SOURCE ViveBio, LLC



Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES